1.
ELISpot for measuring human immune responses to vaccines
by Slota, Meredith
Expert review of vaccines, 2011, Vol.10 (3), p.299-306
2.
Cellular immune response in the presence of protective antibody levels correlates with protection against 1918 influenza in ferrets
by Pillet, Stéphane
Vaccine, 2011, Vol.29 (39), p.6793-6801
3.
Enzyme-linked immunospot assay for interferon-gamma in the diagnosis of tuberculous pleurisy
by Lee, L.-N
Clinical microbiology and infection, 2009, Vol.15 (2), p.173-179
4.
Assessment of Humoral, Innate, and T-Cell Immune Responses to Adeno-Associated Virus Vectors
by Calcedo, Roberto
Human gene therapy. Part B. Methods, 2018, Vol.29 (2), p.86
5.
Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013
by Genito, Christopher J
Vaccine, 2017, Vol.35 (31), p.3865-3874
6.
Nod2-mediated recognition of the microbiota is critical for mucosal adjuvant activity of cholera toxin
by Kim, Donghyun
Nature medicine, 2016, Vol.22 (5), p.524-530
7.
Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection
by Martin, Genevieve E
AIDS (London), 2017, Vol.31 (4), p.477-484
8.
Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine
by Babu, Tara M
Vaccine, 2014, Vol.32 (50), p.6798-6804
9.
The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes
by von Delft, Annette
Vaccine, 2018, Vol.36 (2), p.313-321
10.
Interferon-γ Secretion Enzyme-Linked Immunospot Assay Determined Among Human T Cell Lymphotropic Virus Type 1-Infected Subjects: A Potential Laboratory Marker for Early HTLV-1–Asso...
by Apoliano, Carlos Fernando
AIDS research and human retroviruses, 2019, Vol.36 (1), p.6-7
11.
12.
13.
Interferon gamma (IFN-γ) negative CD4+ and CD8+ T-cells can produce immune mediators in response to viral antigens
by Nakiboneka, Ritah
Vaccine, 2019, Vol.37 (1), p.113-122
14.
The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial
by Geldenhuys, Hennie
Vaccine, 2015, Vol.33 (30), p.3592-3599
15.
16.
Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M
by Venkatraman, Navin
Vaccine, 2017, Vol.35 (45), p.6208-6217
17.
Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania
by Bakari, Muhammad
Vaccine, 2011, Vol.29 (46), p.8417-8428
18.
Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children
by Connell, T G
Thorax, 2006, Vol.61 (7), p.616-620
19.
Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single–dose influenza vaccine protection
by Honda-Okubo, Yoshikazu
Vaccine, 2015, Vol.33 (38), p.4892-4900
20.
Granulocyte-Macrophage Colony-Stimulating Factor-Armed Oncolytic Measles Virus Is an Effective Therapeutic Cancer Vaccine
by Grossardt, Christian
Human gene therapy, 2013, Vol.24 (7), p.644-654
